19136-36-8 Suppliers

Recommended suppliersmore

Product
FOB Price
Min.Order
Supply Ability
Supplier
Contact Supplier

4-bromo-6-tert-butylpyrimidine
Cas No: 19136-36-8
No Data
No Data
No Data
Suzhou Health Chemicals Co., Ltd.
Contact Supplier

4-Bromo-6-tert-butylpyrimidine
Cas No: 19136-36-8
No Data
No Data
No Data
BOC Sciences
Contact Supplier

Pyrimidine, 4-bromo-6-(1,1-dimethylethyl)-
Cas No: 19136-36-8
No Data
No Data
No Data
SAGECHEM LIMITED
Contact Supplier

4-Bromo-6-tert-butylpyrimidine
Cas No: 19136-36-8
No Data
No Data
No Data
Debye Scientific
Contact Supplier

19136-36-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 19136-36-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,1,3 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 19136-36:
(7*1)+(6*9)+(5*1)+(4*3)+(3*6)+(2*3)+(1*6)=108
108 % 10 = 8
So 19136-36-8 is a valid CAS Registry Number.

19136-36-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name	4-bromo-6-tert-butylpyrimidine

1.2 Other means of identification

Product number	-
Other names	6-Brom-4-t-butyl-pyrimidin

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19136-36-8 SDS

19136-36-8Upstream product

3438-49-1 4-hydroxy-6-tert-butylpyrimidine

19136-36-8Downstream Products

19136-36-8Relevant articles and documents

SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

-

Page/Page column 171; 172, (2008/06/13)

The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

SUBSTITUTED UREA AND CARBAMATE, PHENACYL-2-HYDROXY-3-DIAMINOALKANE, AND BENZAMIDE-2-HYDROXY-3-DIAMINOALKANE ASPARTYL-PROTEASE INHIBITORS

-

Page/Page column 291, (2010/02/14)

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating at least one disease, disorder, and condition associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and condition associated with abnormal deposition of A-beta protein.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 19136-36-8

CAS

19136-36-8